Skip to main content
Top

Drugs

Issue 12/2017

Content (9 Articles)

Drugs in Development for Hepatitis B

  • Open Access
  • Leading Article

Altaf Dawood, Syed Abdul Basit, Mahendran Jayaraj, Robert G. Gish

Working Towards an Appropriate Use of Ibuprofen in Children: An Evidence-Based Appraisal

  • Open Access
  • Review Article

Maurizio de Martino, Alberto Chiarugi, Attilio Boner, Giovanni Montini, Gianluigi L. de’ Angelis

Neoadjuvant Therapy for Breast Cancer: Established Concepts and Emerging Strategies

  • Review Article

Tessa G. Steenbruggen, Mette S. van Ramshorst, Marleen Kok, Sabine C. Linn, Carolien H. Smorenburg, Gabe S. Sonke

Therapeutic Utility of Opioids for Restless Legs Syndrome

  • Review Article

Susan E. Mackie, John W. Winkelman

Early Use of Ceftaroline Fosamil in the United States Veterans Health Care System

  • Original Research Article

Rachel S. Britt, Kirk E. Evoy, Grace C. Lee, Kelly R. Reveles, Kimberly M. Sorensen, Xavier Jones, Mary Bollinger, Christopher R. Frei

Insulin Glargine/Lixisenatide: A Review in Type 2 Diabetes

  • Adis Drug Evaluation

Lesley J. Scott

Abaloparatide: First Global Approval

  • AdisInsight Report

Matt Shirley

Durvalumab: First Global Approval

  • Open Access
  • AdisInsight Report

Yahiya Y. Syed

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images